ikarovec

📍 Norwich, United Kingdom🗓 Founded 2018👥 6 employees💰 Last funded May 2022
Biotechnology Research🌐 ikarovec.com
Website LinkedIn
The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in ikarovec?
ikarovec has 1 investors on record on gritt.io, 1 mid-stage.
When did ikarovec last raise funding?
The most recent investment in ikarovec recorded on gritt.io was in May 2022.
When was ikarovec founded?
ikarovec was founded in 2018.
What industry is ikarovec in?
ikarovec operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ikarovec based?
ikarovec is headquartered in Norwich, United Kingdom.